NM
Newtyn Management Portfolio holdings
AUM
$660M
This Quarter Return
-7.05%
1 Year Return
+22.08%
3 Year Return
+41.34%
5 Year Return
+148.8%
10 Year Return
+127.87%
AUM
$533M
AUM Growth
+$533M
(+6.1%)
Cap. Flow
+$59.8M
Cap. Flow
% of AUM
11.23%
Top 10 Holdings %
Top 10 Hldgs %
65.84%
Holding
49
New
9
Increased
10
Reduced
14
Closed
9
Top Buys
| 1 |
QuidelOrtho
QDEL
|
$37M |
| 2 |
Solventum
SOLV
|
$37M |
| 3 |
BrightView Holdings
BV
|
$23.3M |
| 4 |
Sotera Health
SHC
|
$11.3M |
| 5 |
FSP
Franklin Street Properties
FSP
|
$10.9M |
Top Sells
| 1 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
$27.7M |
| 2 |
Cannae Holdings
CNNE
|
$24.2M |
| 3 |
PAR Technology
PAR
|
$12.8M |
| 4 |
Mitek Systems
MITK
|
$10.7M |
| 5 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
$10.1M |
Sector Composition
| 1 | Healthcare | 30.47% |
| 2 | Communication Services | 18.1% |
| 3 | Real Estate | 13.17% |
| 4 | Technology | 12.06% |
| 5 | Energy | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Wave Life Sciences
WVE
$1.27B
| $2.37M | 0.45% |
475,000
-25,000
| -5% | -$125K |
|
|
27
Mitek Systems
MITK
$444M
| $2.23M | 0.42% |
199,698
-958,865
| -83% | -$10.7M |
|
28
Kodiak Sciences
KOD
$453M
| $2.19M | 0.41% |
930,000
-70,000
| -7% | -$165K |
|
29
89bio
ETNB
$1.37B
| $1.92M | 0.36% |
240,000
-10,000
| -4% | -$80.1K |
|
30
Mural Oncology
MURA
$35.9M
| $1.79M | 0.34% |
570,000
+70,000
| +14% | +$220K |
|
31
Abeona Therapeutics
ABEO
$356M
| $1.61M | 0.3% |
+380,000
| New | +$1.61M |
|
32
Olema Pharmaceuticals
OLMA
$432M
| $1.51M | 0.28% |
140,000
-10,000
| -7% | -$108K |
|
33
Atea Pharmaceuticals
AVIR
$275M
| $1.26M | 0.24% |
380,000
-20,000
| -5% | -$66.2K |
|
34
Bolt Biotherapeutics
BOLT
$9.29M
| $1.02M | 0.19% |
1,363,234
-336,766
| -20% | -$253K |
|
|
GRAL
35
GRAIL, Inc. Common Stock
GRAL
$1.17B
| $527K | 0.1% |
+34,269
| New | +$527K |
|
36
Black Diamond Therapeutics
BDTX
$164M
| $443K | 0.08% |
95,000
-30,000
| -24% | -$140K |
|
37
Forum Energy Technologies
FET
$304M
| $253K | 0.05% |
15,000
-179,300
| -92% | -$3.02M |
|
38
Aligos Therapeutics
ALGS
$75.1M
| $252K | 0.05% |
719,287
-480,713
| -40% | -$168K |
|
|
LFLYW
39
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
| $9.84K | ﹤0.01% |
634,640
| – | – |
|
|
MACK
40
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| – | – |
-1,873,694
| Closed | -$27.7M |
|
|
CDMO
41
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| – | – |
-1,500,000
| Closed | -$10.1M |
|
|
TECX
42
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
| – | – |
-1,118,892
| Closed | -$1.43M |
|
43
Vanda Pharmaceuticals
VNDA
$279M
| – | – |
-311,000
| Closed | -$1.28M |
|
44
Sensei Biotherapeutics
SNSE
$10.9M
| – | – |
-930,230
| Closed | -$977K |
|
45
Phathom Pharmaceuticals
PHAT
$843M
| – | – |
-165,000
| Closed | -$1.75M |
|
46
Algoma Steel
ASTL
$504M
| – | – |
-590,899
| Closed | -$5.02M |
|
47
Adverum Biotechnologies
ADVM
$68.2M
| – | – |
-46,189
| Closed | -$653K |
|
48
Adaptive Biotechnologies
ADPT
$1.96B
| – | – |
-623,690
| Closed | -$2M |
|